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Rainforest gives way to pastures in the 
Brazilian Amazon in Mato Grosso.
LETTERS
with Brazil conditional on: (i) uphold-
ing the United Nations Declaration on 
the Rights of Indigenous Peoples; (ii) 
improving procedures to trace com-
modities associated with deforestation 
and Indigenous rights conflicts; and (iii) 
consulting with, and gaining consent from, 
Indigenous Peoples and local communities 
to define strict social and environmental 
criteria for traded commodities. 
The EU was founded on the principles 
of respecting human rights and human 
dignity. Today, it has the opportunity to be 
a global leader in supporting these prin-
ciples and a habitable climate by making 
sustainability the cornerstone of its trade 
negotiations with Brazil.
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Evidence supports 
prediabetes treatment
In his News Feature on prediabetes 
(“Dubious diagnosis,” 8 March, p. 1026), 
C. Piller asserts that prediabetes diag-
noses and treatment may be ineffective 
and sullied by conflicts of interest. 
As current and former chairs of the 
American Diabetes Association’s (ADA’s) 
Professional Practice Committee [the 
group that reviews and updates the 
Standards of Medical Care in Diabetes 
(Standards) each year], we disagree. 
Prediabetes is a useful term to convey 
future risk of diabetes, and recommenda-
tions for diabetes prevention are based on 
best current evidence. 
The ADA classifies prediabetes as a risk 
factor for diabetes that can be mitigated 
by lifestyle changes or, in limited circum-
stances, with the addition of metformin. 
Piller reports that prediabetes does little 
or no harm on its own and that fewer than 
2% of people with prediabetes progress to 
diabetes each year. The risk of progressing 
from prediabetes to diabetes varies accord-
ing to the diagnostic criteria used (1), but 
even a 2% progression rate per year would 
translate to nearly 1 of 5 people with predi-
abetes developing diabetes within 10 years. 
Also, many individuals with prediabetes 
have a multiplicity of risk, due to ethnicity, 
body weight, and other factors, and these 
may render their annual risk much higher.
In the online “Key takeaways” box 
(https://scim.ag/prediabetes), Piller states 
that “Many studies suggest that for most 
people the usual treatments for prediabetes, 
diet and exercise, do little to further reduce 
the risk of diabetes.” However, healthy eat-
ing and regular physical activity (2) have 
been shown (along with the medication 
Make EU trade with 
Brazil sustainable
Brazil, home to one of the planet’s last 
great forests, is currently in trade nego-
tiations with its second largest trading 
partner, the European Union (EU). We 
urge the EU to seize this critical opportu-
nity to ensure that Brazil protects human 
rights and the environment. 
Brazil’s forests, wetlands, and savannas 
are crucial to a great diversity of Indigenous 
peoples, the stability of our global climate, 
and biodiversity conservation (1). By work-
ing toward dismantling anti-deforestation 
policies, Brazil’s new administration threat-
ens Indigenous rights and the natural areas 
they protect (2).
The EU spent more than €3 billion on 
Brazilian iron imports in 2017 (3), despite 
perilous safety standards and extensive 
deforestation driven by mining (4). In 2011 
alone, the EU imported beef and livestock 
feed associated with more than 1000 km2 
of Brazilian deforestation [equivalent to 
more than 300 football fields per day (5)]. 
The EU thus urgently needs to strengthen 
efforts on sustainable trade (6–8) and 
uphold its commitments on human rights, 
environmental protection, and climate 
change mitigation (9). 
Halting deforestation makes eco-
nomic sense, as intact forests are critical 
to maintaining the rainfall patterns on 
which Brazilian agriculture depends (10). 
Restoring degraded lands and improv-
ing yields could meet rising agricultural 
demand for at least two decades without 
need for further forest clearance (11). 
We urge the EU to make trade negotiations 
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metformin for select patients) to delay or 
prevent progression to diabetes (3–5). 
Accordingly, the Standards place a heavy 
emphasis on these lifestyle interventions.
Piller writes that the ADA lists costly 
medications for diabetes prevention, sold 
by pharmaceutical companies from which 
Professional Practice Committee members 
have collected “large sums.” We disagree 
that this funding affected the commit-
tee’s positions. No pharmaceutical agents 
have been FDA-approved for diabetes 
prevention, and the only recommended 
medication is metformin, which has been 
shown to be effective and safe (3, 6) and 
is available for as little as $4 per month 
[e.g., (7)], rendering the conflicts of inter-
est described in the article irrelevant to 
the current ADA recommendations for 
diabetes prevention. In fact, metformin 
may save costs over a 10-year period when 
used for diabetes prevention (6). The 
Standards of Care mentions pharmacologic 
agents other than metformin, including 
glucose-lowering and weight loss thera-
pies that have been studied for diabetes 
prevention (3), but these agents are not 
recommended by the ADA for diabetes pre-
vention. Additionally, the ADA states that 
metformin should be considered for those 
who have prediabetes, especially those who 
have a body mass index (BMI) of at least 
35 kg/m2, are under the age of 60 years, or 
have a history of gestational diabetes mel-
litus (2). These recommendations highlight 
the importance of risk stratification and 
individualization of therapy. 
We acknowledge that unanswered 
questions surrounding prediabetes and 
its management remain important issues 
that warrant open discussion. Indeed, the 
ADA has not shied away from such debate 
(8, 9). It is important to engage in these 
discussions with full consideration of the 
available evidence.
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Pay to protect at-risk 
bycatch species
The incidental capture of threatened species 
as bycatch is placing global biodiversity at 
risk (1, 2), particularly in developing coun-
tries where small-scale fishing and hunting 
often rely on unselective capture methods (3, 
4). To address this, the Indian Maharashtra 
state government recently announced that 
it will financially compensate fishers who 
release incidentally captured endangered 
species. Payment will be made based on 
photographic evidence of the captured 
individual and proof that fishing gear was 
damaged to allow the release (5). 
Financially incentivizing the release of 
threatened bycatch considers the needs of 
fishers and hunters whose actions often 
have direct consequences for conservation 
(6, 7). As a result of a similar pay-for-
release program, Kenyan fishers have 
released about 17,000 threatened bycaught 
sea turtles over the past two decades (8). 
This positive outcome underscores clear 
and measurable conservation gains, yet 
pay-for-release schemes remain a rarely 
used conservation strategy. 
Instead, tackling the issue of bycatch 
mostly relies on modifying capture gear, 
education, and enforcing legislation (1, 
2, 9), approaches that commonly require 
long-term investment for positive outcomes 
(3, 4, 10). The pay-for-release strategy could 
provide a rapid, complementary mechanism 
to ease pressure on threatened species, such 
as sawfishes (11), that are not the focus of 
harvest and require immediate conservation 
action (5, 12). The Maharashtra government, 
and any local governments that follow suit, 
should explore a broad range of scenarios 
and collect results to determine the most 
effective way to implement this type of pro-
gram and to assess its effectiveness. 
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India is emulating Kenya’s bycatch release program, 
which protects endangered green sea turtles. PH
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